| ||
| Stock Updates: CYTX, NEOP, AIG Stock Market Weekly Neoprobe Corporation reports Phase 2 results of Lymphoseek; demonstrates the tracing agent's ability to identify tumor-draining lymph nodes in breast cancer and melanoma patients. American International Group, Inc. (Public, NYSE:AIG) (Price: 38.54 ... See all stories on this topic » | ||
| HOW THE DISCOVERY OF A FAULTY GENE MAY BE KEY TO BEATING CANCER Express.co.uk By Jo Willey SCIENTISTS are a step closer to beating cancer after discovering how a rare type of the disease can heal itself. It could pave the way for new drugs to treat a range of tumours, including breast and bowel cancer. ... See all stories on this topic » |
| ||
| COX Enzyme | Pharmainfo.net By gangadhar hari The main difference between the two isoforms that leads to selective inhibition by various drugs is that the Isoleucine at position s 434 and 523 in COX-1 is exchanged for Valine in COX-2. Therapeutic Outcomes By inhibition of COX [3] ... COX-2 inhibitors are currently being studied for their activity against breast cancer, colorectal cancer and appear to be beneficial.[7]. References: 1. http:/ /osteoarthritis.about.com/od/osteoarthritismedications/a/cyclooxyg. ... Pharmainfo.net - http://www.pharmainfo.net/ |
| ||
| Key breast cancer 'driver' gene found | Great News Network "This is exciting because it's a prime candidate for the development of new breast cancer drugs designed specifically to target tumours in which this gene ... www.greatnewsnetwork.org/.../key_breast_cancer_driver_gen... |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment